No specific IC50 values were disclosed but it claimed to be <10 nM against CDK9 in biochemical assay and <1 nM against cell growth in cell-based assay using 44 CDK9-expressing tumour cell lines, including human acute leukaemia MOM13 cells. The gene discussed is CDK9; the disease is neoplasm.